Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding

Human immunodeficiency virus (HIV) binds to cells via an interaction between CD4 and the virus envelope glycoprotein, gp120. Previous studies have localized the high affinity binding site for gp120 to the first domain of CD4, and monoclonal antibodies (mAbs) reactive with this region compete with gp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 1990-10, Vol.172 (4), p.1233-1242
Hauptverfasser: HEALEY, D, DIANDA, L, MOORE, J. P, MCDOUGAL, J. S, MOORE, M. J, ESTESS, P, BUCK, D, KWONG, P. D, BEVERLEY, P. C. L, SATTENTAU, Q. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1242
container_issue 4
container_start_page 1233
container_title The Journal of experimental medicine
container_volume 172
creator HEALEY, D
DIANDA, L
MOORE, J. P
MCDOUGAL, J. S
MOORE, M. J
ESTESS, P
BUCK, D
KWONG, P. D
BEVERLEY, P. C. L
SATTENTAU, Q. J
description Human immunodeficiency virus (HIV) binds to cells via an interaction between CD4 and the virus envelope glycoprotein, gp120. Previous studies have localized the high affinity binding site for gp120 to the first domain of CD4, and monoclonal antibodies (mAbs) reactive with this region compete with gp120 binding and thereby block virus infectivity and syncytium formation. Despite a detailed understanding of the binding of gp120 to CD4, little is known of subsequent events leading to membrane fusion and virus entry. We describe two new mAbs reactive with the third domain of CD4 that inhibit steps subsequent to virus binding critical for HIV infectivity and cell fusion. Binding of recombinant gp120 or virus to CD4 is not inhibited by these antibodies, whereas infection and syncytium formation by a number of HIV isolates are blocked. These findings demonstrate that in addition to virus binding, CD4 may have an active role in membrane fusion.
doi_str_mv 10.1084/jem.172.4.1233
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2188592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80042820</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-bee8cd0c96386147325ac328777b95b2825c42c43a8f9757485193533cd17af73</originalsourceid><addsrcrecordid>eNpVkb1vFDEQxS1EFI5AS4fkBhq0G3-u7QYpOj6lKDRQW16vnTha24e9e1I6_vT4dCcC1VjzfvM8owfAG4x6jCS7vHexx4L0rMeE0mdggzlDneJUPgcbhAjpMELiBXhZ6z1CmDE-nINzPCipMN6APzd572Zo0hK67ScGY07ZzjmZY2_MU3AVVrczxSwO3q3RJBhiXFOenA82uGQf4D6UtcKQvLNLyKmNTtCv9fDMHjbfD9C6ea7QlxxP9BjSFNLtK3DmzVzd61O9AL--fP65_dZd__j6fXt13Vkm8dKNzkk7IasGKgfMBCXcWEqkEGJUfCSScMuIZdRIrwQXTHKsKKfUTlgYL-gF-Hj03a1jdJN1aSlm1rsSoikPOpug_1dSuNO3ea8JlpIr0gzenwxK_r26uugY6uEqk1xeq5YIsbYGamB_BG3JtRbn_36CkT5kpltmumWmmT5k1gbe_rvaE34MqenvTrqp1sy-mGRDfcLUMLTzFX0EZm-hgA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80042820</pqid></control><display><type>article</type><title>Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>HEALEY, D ; DIANDA, L ; MOORE, J. P ; MCDOUGAL, J. S ; MOORE, M. J ; ESTESS, P ; BUCK, D ; KWONG, P. D ; BEVERLEY, P. C. L ; SATTENTAU, Q. J</creator><creatorcontrib>HEALEY, D ; DIANDA, L ; MOORE, J. P ; MCDOUGAL, J. S ; MOORE, M. J ; ESTESS, P ; BUCK, D ; KWONG, P. D ; BEVERLEY, P. C. L ; SATTENTAU, Q. J</creatorcontrib><description>Human immunodeficiency virus (HIV) binds to cells via an interaction between CD4 and the virus envelope glycoprotein, gp120. Previous studies have localized the high affinity binding site for gp120 to the first domain of CD4, and monoclonal antibodies (mAbs) reactive with this region compete with gp120 binding and thereby block virus infectivity and syncytium formation. Despite a detailed understanding of the binding of gp120 to CD4, little is known of subsequent events leading to membrane fusion and virus entry. We describe two new mAbs reactive with the third domain of CD4 that inhibit steps subsequent to virus binding critical for HIV infectivity and cell fusion. Binding of recombinant gp120 or virus to CD4 is not inhibited by these antibodies, whereas infection and syncytium formation by a number of HIV isolates are blocked. These findings demonstrate that in addition to virus binding, CD4 may have an active role in membrane fusion.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.172.4.1233</identifier><identifier>PMID: 1698911</identifier><identifier>CODEN: JEMEAV</identifier><language>eng</language><publisher>New York, NY: Rockefeller University Press</publisher><subject>AIDS/HIV ; Animals ; Antibodies, Monoclonal - immunology ; Binding Sites ; Biological and medical sciences ; CD4 Antigens - immunology ; CD4 Antigens - physiology ; CD4-Positive T-Lymphocytes - microbiology ; Cell Fusion ; Epitopes - analysis ; Fundamental and applied biological sciences. Psychology ; HIV Envelope Protein gp120 - metabolism ; HIV Infections - prevention &amp; control ; Mice ; Mice, Inbred BALB C ; Microbiology ; Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains ; Virology</subject><ispartof>The Journal of experimental medicine, 1990-10, Vol.172 (4), p.1233-1242</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-bee8cd0c96386147325ac328777b95b2825c42c43a8f9757485193533cd17af73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19668259$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1698911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HEALEY, D</creatorcontrib><creatorcontrib>DIANDA, L</creatorcontrib><creatorcontrib>MOORE, J. P</creatorcontrib><creatorcontrib>MCDOUGAL, J. S</creatorcontrib><creatorcontrib>MOORE, M. J</creatorcontrib><creatorcontrib>ESTESS, P</creatorcontrib><creatorcontrib>BUCK, D</creatorcontrib><creatorcontrib>KWONG, P. D</creatorcontrib><creatorcontrib>BEVERLEY, P. C. L</creatorcontrib><creatorcontrib>SATTENTAU, Q. J</creatorcontrib><title>Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>Human immunodeficiency virus (HIV) binds to cells via an interaction between CD4 and the virus envelope glycoprotein, gp120. Previous studies have localized the high affinity binding site for gp120 to the first domain of CD4, and monoclonal antibodies (mAbs) reactive with this region compete with gp120 binding and thereby block virus infectivity and syncytium formation. Despite a detailed understanding of the binding of gp120 to CD4, little is known of subsequent events leading to membrane fusion and virus entry. We describe two new mAbs reactive with the third domain of CD4 that inhibit steps subsequent to virus binding critical for HIV infectivity and cell fusion. Binding of recombinant gp120 or virus to CD4 is not inhibited by these antibodies, whereas infection and syncytium formation by a number of HIV isolates are blocked. These findings demonstrate that in addition to virus binding, CD4 may have an active role in membrane fusion.</description><subject>AIDS/HIV</subject><subject>Animals</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>CD4 Antigens - immunology</subject><subject>CD4 Antigens - physiology</subject><subject>CD4-Positive T-Lymphocytes - microbiology</subject><subject>Cell Fusion</subject><subject>Epitopes - analysis</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV Envelope Protein gp120 - metabolism</subject><subject>HIV Infections - prevention &amp; control</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Microbiology</subject><subject>Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains</subject><subject>Virology</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkb1vFDEQxS1EFI5AS4fkBhq0G3-u7QYpOj6lKDRQW16vnTha24e9e1I6_vT4dCcC1VjzfvM8owfAG4x6jCS7vHexx4L0rMeE0mdggzlDneJUPgcbhAjpMELiBXhZ6z1CmDE-nINzPCipMN6APzd572Zo0hK67ScGY07ZzjmZY2_MU3AVVrczxSwO3q3RJBhiXFOenA82uGQf4D6UtcKQvLNLyKmNTtCv9fDMHjbfD9C6ea7QlxxP9BjSFNLtK3DmzVzd61O9AL--fP65_dZd__j6fXt13Vkm8dKNzkk7IasGKgfMBCXcWEqkEGJUfCSScMuIZdRIrwQXTHKsKKfUTlgYL-gF-Hj03a1jdJN1aSlm1rsSoikPOpug_1dSuNO3ea8JlpIr0gzenwxK_r26uugY6uEqk1xeq5YIsbYGamB_BG3JtRbn_36CkT5kpltmumWmmT5k1gbe_rvaE34MqenvTrqp1sy-mGRDfcLUMLTzFX0EZm-hgA</recordid><startdate>19901001</startdate><enddate>19901001</enddate><creator>HEALEY, D</creator><creator>DIANDA, L</creator><creator>MOORE, J. P</creator><creator>MCDOUGAL, J. S</creator><creator>MOORE, M. J</creator><creator>ESTESS, P</creator><creator>BUCK, D</creator><creator>KWONG, P. D</creator><creator>BEVERLEY, P. C. L</creator><creator>SATTENTAU, Q. J</creator><general>Rockefeller University Press</general><general>The Rockefeller University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19901001</creationdate><title>Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding</title><author>HEALEY, D ; DIANDA, L ; MOORE, J. P ; MCDOUGAL, J. S ; MOORE, M. J ; ESTESS, P ; BUCK, D ; KWONG, P. D ; BEVERLEY, P. C. L ; SATTENTAU, Q. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-bee8cd0c96386147325ac328777b95b2825c42c43a8f9757485193533cd17af73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>AIDS/HIV</topic><topic>Animals</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>CD4 Antigens - immunology</topic><topic>CD4 Antigens - physiology</topic><topic>CD4-Positive T-Lymphocytes - microbiology</topic><topic>Cell Fusion</topic><topic>Epitopes - analysis</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV Envelope Protein gp120 - metabolism</topic><topic>HIV Infections - prevention &amp; control</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Microbiology</topic><topic>Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HEALEY, D</creatorcontrib><creatorcontrib>DIANDA, L</creatorcontrib><creatorcontrib>MOORE, J. P</creatorcontrib><creatorcontrib>MCDOUGAL, J. S</creatorcontrib><creatorcontrib>MOORE, M. J</creatorcontrib><creatorcontrib>ESTESS, P</creatorcontrib><creatorcontrib>BUCK, D</creatorcontrib><creatorcontrib>KWONG, P. D</creatorcontrib><creatorcontrib>BEVERLEY, P. C. L</creatorcontrib><creatorcontrib>SATTENTAU, Q. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HEALEY, D</au><au>DIANDA, L</au><au>MOORE, J. P</au><au>MCDOUGAL, J. S</au><au>MOORE, M. J</au><au>ESTESS, P</au><au>BUCK, D</au><au>KWONG, P. D</au><au>BEVERLEY, P. C. L</au><au>SATTENTAU, Q. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>1990-10-01</date><risdate>1990</risdate><volume>172</volume><issue>4</issue><spage>1233</spage><epage>1242</epage><pages>1233-1242</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><coden>JEMEAV</coden><abstract>Human immunodeficiency virus (HIV) binds to cells via an interaction between CD4 and the virus envelope glycoprotein, gp120. Previous studies have localized the high affinity binding site for gp120 to the first domain of CD4, and monoclonal antibodies (mAbs) reactive with this region compete with gp120 binding and thereby block virus infectivity and syncytium formation. Despite a detailed understanding of the binding of gp120 to CD4, little is known of subsequent events leading to membrane fusion and virus entry. We describe two new mAbs reactive with the third domain of CD4 that inhibit steps subsequent to virus binding critical for HIV infectivity and cell fusion. Binding of recombinant gp120 or virus to CD4 is not inhibited by these antibodies, whereas infection and syncytium formation by a number of HIV isolates are blocked. These findings demonstrate that in addition to virus binding, CD4 may have an active role in membrane fusion.</abstract><cop>New York, NY</cop><pub>Rockefeller University Press</pub><pmid>1698911</pmid><doi>10.1084/jem.172.4.1233</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1007
ispartof The Journal of experimental medicine, 1990-10, Vol.172 (4), p.1233-1242
issn 0022-1007
1540-9538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2188592
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects AIDS/HIV
Animals
Antibodies, Monoclonal - immunology
Binding Sites
Biological and medical sciences
CD4 Antigens - immunology
CD4 Antigens - physiology
CD4-Positive T-Lymphocytes - microbiology
Cell Fusion
Epitopes - analysis
Fundamental and applied biological sciences. Psychology
HIV Envelope Protein gp120 - metabolism
HIV Infections - prevention & control
Mice
Mice, Inbred BALB C
Microbiology
Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains
Virology
title Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A03%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20anti-CD4%20monoclonal%20antibodies%20separate%20human%20immunodeficiency%20virus%20infection%20and%20fusion%20of%20CD4+%20cells%20from%20virus%20binding&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=HEALEY,%20D&rft.date=1990-10-01&rft.volume=172&rft.issue=4&rft.spage=1233&rft.epage=1242&rft.pages=1233-1242&rft.issn=0022-1007&rft.eissn=1540-9538&rft.coden=JEMEAV&rft_id=info:doi/10.1084/jem.172.4.1233&rft_dat=%3Cproquest_pubme%3E80042820%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80042820&rft_id=info:pmid/1698911&rfr_iscdi=true